carteolol has been researched along with Angina Pectoris in 6 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a multicenter, dose-ranging, double-blind study, 63 patients diagnosed as having stable angina pectoris were randomly assigned to treatment with carteolol (33 patients) or nadolol (30 patients)." | 9.06 | A comparison of carteolol and nadolol in the treatment of stable angina pectoris. ( Glassman, HN; Jordan, DC; Luther, RR, 1988) |
| "Seventy-two patients entered the treatment phase of an open, long-term, dose-ranging trial of carteolol in stable, exercise-induced angina pectoris." | 7.67 | Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent. ( Glassman, HN; Jordan, DC; Klepper, MJ; Luther, RR, 1986) |
| "In a multicenter, dose-ranging, double-blind study, 63 patients diagnosed as having stable angina pectoris were randomly assigned to treatment with carteolol (33 patients) or nadolol (30 patients)." | 5.06 | A comparison of carteolol and nadolol in the treatment of stable angina pectoris. ( Glassman, HN; Jordan, DC; Luther, RR, 1988) |
| "Seventy-two patients entered the treatment phase of an open, long-term, dose-ranging trial of carteolol in stable, exercise-induced angina pectoris." | 3.67 | Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent. ( Glassman, HN; Jordan, DC; Klepper, MJ; Luther, RR, 1986) |
| "Publications dealing with the results of treating coronary heart disease patients with 5-(3-tert-butylamino-2-hydroxy-propoxy)-3, 4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) are reviewed." | 3.66 | [Clinical experiences in patients with coronary heart disease and angina pectoris]. ( Sölter, H, 1983) |
| " The dose-response relation and duration of action of the beta-blocking agent 5-(3-tert-butylamino-2-hydroxy-propoxy)-3,4-dihydro-2(1H)-quinolinone hydrochloride (carteolol hydrochloride, Endak, Endak mite) were investigated by means of exercise testing under randomized, double-blind conditions in two groups of healthy probands (n = 9 and n = 9, respectively)." | 2.65 | [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect]. ( Kaltenbach, M; Kober, G; Mikludy, R; Veidt, J, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, H | 1 |
| Schuppan, U | 1 |
| Sölter, H | 1 |
| Kober, G | 1 |
| Veidt, J | 1 |
| Mikludy, R | 1 |
| Kaltenbach, M | 1 |
| Luther, RR | 2 |
| Glassman, HN | 2 |
| Jordan, DC | 2 |
| Klepper, MJ | 1 |
| Liu, PH | 1 |
| Lai, WY | 1 |
| Chen, CY | 1 |
| Shieh, SM | 1 |
3 trials available for carteolol and Angina Pectoris
| Article | Year |
|---|---|
The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
Topics: Adult; Aging; Angina Pectoris; Carteolol; Clinical Trials as Topic; Electrocardiography; Female; Hum | 1983 |
[Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
Topics: Adult; Angina Pectoris; Carteolol; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind | 1983 |
A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carteolol; Clinical Trials as Topic; Double-Blind M | 1988 |
3 other studies available for carteolol and Angina Pectoris
| Article | Year |
|---|---|
[Clinical experiences in patients with coronary heart disease and angina pectoris].
Topics: Angina Pectoris; Blood Pressure; Carteolol; Coronary Disease; Electrocardiography; Female; Heart Rat | 1983 |
Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
Topics: Adult; Aged; Angina Pectoris; Carteolol; Drug Therapy, Combination; Female; Heart Function Tests; Hu | 1986 |
[A comparative study of carteolol and propranolol on exercise performance in patients with chronic stable angina pectoris].
Topics: Aged; Angina Pectoris; Carteolol; Chronic Disease; Exercise Test; Female; Humans; Male; Middle Aged; | 1985 |